You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Disposable Amperometric Lithium Ion-selective Electrode for Home Testing

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    Not Available

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  2. A Next-Generation Split Hook Prehensor with Enhanced Grasp Functionality

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Owing to certain intrinsic advantages, a surprisingly large number of upper-extremity amputees prefer simple cable operated prostheses and split hook terminal devices for many activities. For disadvantaged amputees in the United States and in developing countries, such systems often present the only viable restorative option. ADA Technologies and its supportin ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  3. A Low-Cost Upper-Extremity Prosthetic Interface

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Remarkable advances in signal processing techniques, materials sciences, battery technologies, and computer-aided design and computer-aided manufacturing (CAD/CAM) processes have led to significant developments in assistive technologies. Coordinated research and commercialization have dramatically increased prosthetic function, utility, personalization, comfor ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  4. Novel 3-dimensional (3-D) platform for high-throughput glycomics analysis

    SBC: ADA TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Glycan (carbohydrate microarrays), carrying tens or hundreds of different sugars that are immobilized on solid surfaces in a spatially discrete pattern, possess a wide variety of potential applications in glycomics including rapid determination of the binding profile of carbohydrate-binding proteins, detection of specific antibodies for the diagnosis of disease ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  5. Cardiac Cryoablation Catheter

    SBC: ADVANCED REFRIGERATION TECHNOLOGIES, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Atrial fibrillation (AF) is the most frequent arrhythmia encountered in clinical practice and is the most common arrhythmia necessitating hospital admission. Nearly three million people in the U.S. have Atrial Fibrillation. Americans over 40 have a one in four lifetime risk of developing Atrial Fibrillation. Currently there is only one practical treatment, pulm ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  6. Long-Acting G-CSF analogs for treating acute radiation syndrome

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION (provided by applicant): Development of radiological/nuclear medical countermeasures to treat Acute Radiation Syndrome (ARS) is a high priority research area for NIAID. Bone marrow is one of the most sensitive tissues to radiation damage and impaired hematopoiesis is one of the first clinical signs of excessive radiation exposure, often resulting in death. Granulocyte colony-stimul ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  7. GM-CSF analogs for treating acute radiation syndrome

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION (provided by applicant): Development of radiological/nuclear medical countermeasures to treat Acute Radiation Syndrome (ARS) is a high priority research area for NIAID. Bone marrow is one of the most sensitive tissues to radiation damage and impaired bone marrow hematopoiesis is one of the first clinical signs of excessive radiation exposure, often leading to death. Granulocyte-mac ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  8. Long-acting EPO analog for treating anemia associated with chronic kidney disease

    SBC: BOLDER BIOTECHNOLOGY INC            Topic: N/A

    DESCRIPTION (provided by applicant): Anemia is a frequent finding in patients with chronic kidney disease (CKD) and is present in over 90% of CKD patients with end-stage renal disease. Anemia typically results from inability of the diseased kidney to produce erythropoietin (EPO), which stimulates production of red blood cells. Anemia leads to fatigue, a decreased quality of life and correlates wit ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  9. Connecting Elders, Empowering Caregivers

    SBC: CARINGFAMILY, LLC            Topic: NIA

    DESCRIPTION (provided by applicant): This proposal is in response to Notice Number (NOT-OD-09-058) and Notice Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications. We propose to adapt for an assisted living environment the Family Connections System (FCS) and Digital Mailbox technology which offer communication tools designed to increase the frequency an ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  10. Natural Mixtures from Expired Human Platelets for Periodontal Tissue Engineering

    SBC: SNOASIS MEDICAL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Some 1.8 million regenerative dental procedures were done in the U.S. in 2006. Of these, about 20% used a wound-healant product such as a recombinant growth factor (RGF) or concentrates of a patient's own platelets [requiring the use of a platelet concentrating system (PCS)]. Wound-healants are used as an attempt to accelerate healing and to improve patient ou ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government